- Report
- December 2023
- 231 Pages
Global
€4620EUR$4,995USD£3,856GBP
- Report
- September 2025
- 150 Pages
Global
From €4486EUR$4,850USD£3,744GBP
- Report
- September 2025
- 150 Pages
Global
From €4486EUR$4,850USD£3,744GBP
- Report
- June 2025
- 150 Pages
Global
From €4486EUR$4,850USD£3,744GBP
- Report
- May 2026
- 11 Pages
Global
From €462EUR$499USD£385GBP
- Report
- October 2025
- 160 Pages
Global
From €2923EUR$3,160USD£2,439GBP
€3653EUR$3,950USD£3,049GBP
- Report
- October 2025
- 160 Pages
Global
From €2923EUR$3,160USD£2,439GBP
€3653EUR$3,950USD£3,049GBP
- Report
- October 2025
- 160 Pages
Global
From €2923EUR$3,160USD£2,439GBP
€3653EUR$3,950USD£3,049GBP
- Report
- October 2025
- 160 Pages
Global
From €2923EUR$3,160USD£2,439GBP
€3653EUR$3,950USD£3,049GBP
- Report
- October 2025
- 160 Pages
Global
From €2923EUR$3,160USD£2,439GBP
€3653EUR$3,950USD£3,049GBP
- Report
- October 2025
- 160 Pages
Global
From €2923EUR$3,160USD£2,439GBP
€3653EUR$3,950USD£3,049GBP
- Report
- October 2025
- 160 Pages
Global
From €2923EUR$3,160USD£2,439GBP
€3653EUR$3,950USD£3,049GBP
- Report
- August 2025
- 150 Pages
Global
From €2923EUR$3,160USD£2,439GBP
€3653EUR$3,950USD£3,049GBP
- Report
- August 2025
- 150 Pages
Global
From €2923EUR$3,160USD£2,439GBP
€3653EUR$3,950USD£3,049GBP
- Report
- July 2024
- 153 Pages
Global
From €3145EUR$3,400USD£2,624GBP
€3931EUR$4,250USD£3,281GBP
- Report
- September 2025
- 150 Pages
Global
From €4116EUR$4,450USD£3,435GBP
- Report
- July 2024
- 108 Pages
Africa, Middle East
From €3191EUR$3,450USD£2,663GBP
- Report
- January 2024
- 95 Pages
Middle East, Africa
From €3191EUR$3,450USD£2,663GBP
- Report
- December 2023
- 150 Pages
Global
From €4116EUR$4,450USD£3,435GBP
From €3191EUR$3,450USD£2,663GBP

The CRISPR market is a subset of the genomics market that focuses on the use of CRISPR-Cas9 technology for gene editing. CRISPR-Cas9 is a powerful tool that enables scientists to make precise changes to the genome of living organisms. This technology has been used to develop treatments for a variety of diseases, as well as to create new crops and livestock. CRISPR-Cas9 technology has also been used to create gene drives, which are designed to spread a desired trait through a population.
The CRISPR market is highly competitive, with a number of companies offering products and services related to gene editing. These companies include Editas Medicine, Intellia Therapeutics, CRISPR Therapeutics, Caribou Biosciences, and ERS Genomics. These companies are developing a range of products, from gene editing tools to gene therapies, and are working to make CRISPR-Cas9 technology more accessible and affordable. Show Less Read more